Thursday, December 27, 2007

Cigna HealthCare refused to pay to transplant an available liver into a 17-year-old

How does an insurance company make $1.2 billion in profits? By allowing this teenager and others to die.

December 21st, 2007
Insurer's U-turn too late to save life of transplant teenager

By Ed Pilkington / Guardian

The family of a California teenager plan to sue her health insurer which refused to pay for a liver transplant until hours before and she died on Thursday night.

Her family's lawyer, Mark Geragos, will ask the Los Angeles district attorney to press murder or manslaughter charges against Cigna HealthCare, arguing that the firm "maliciously killed" Nataline Sarkisyan by its reluctance to pay for her treatment. The company reversed its stance after protesters called for a rethink, but the decision came too late.

The 17-year-old from Glendale, California, had been in a coma for weeks after complications following a bone marrow transplant to counter leukaemia.

After the operation, her liver failed and doctors referred her for an emergency transplant. Although she was fully insured and had a matching donor, Cigna refused to pay on the grounds that her healthcare plan "does not cover experimental, investigational and unproven services".

Cigna's rejection on December 11 led Sarkisyan's doctors at UCLA medical centre, including the head of its transplant unit, to write a letter to protest that the treatment which they proposed was neither experimental nor unproven. They called on the firm to urgently review its decision.

In the absence of a response from Cigna, doctors told the Sarkisyan family that the only alternative would be for the family to pay. But they could not afford the immediate down payment of $75,000 (£38,000).

..."This is what's wrong with our health system - insurers decide treatment, not doctors."

The protests over Sarkisyan's case point to growing public disenchantment with the healthcare system in America...

The company recently posted figures for its third-quarter performance this year, which showed profits up 22%. Next year it expects to earn an income of up to $1.2bn.

http://www.michaelmoore.com/words/mikeinthenews/index.php?id=10581

No comments: